CAS: 24622-72-8; 1-[2-(3-Methylbutoxy)-2-Phenylethyl]Pyrrolidine

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-8546532-B2
      优先权日:2008-04-17
      标题:Synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
      发明人:BONNIN DUSTAN; ZANELLI ERIC; MATHERS THOMAS
      权利人:BONNIN DUSTAN; ZANELLI ERIC; MATHERS THOMAS; DECLION PHARMACEUTICALS INC
      摘要:The instant invention comprises a process for the solid phase synthesis of directed epitope peptide mixtures useful in the treatment and diagnosis of protein conformational disorders, such process defined by a set of rules regarding the identity and the frequency of occurrence of amino acids that substitute a base or native amino acid of a known epitope. The resulting composition is a mixture of related peptides for therapeutic use. The invention also pertains to the process of generating antibodies using the directed epitope peptide mixtures as the antigens, and antibodies generated by such process, useful in the treatment and diagnostics of the said protein conformational disorder.

      专利号:US-2024287041-A1
      优先权日:2021-05-20
      标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
      发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
      权利人:KARYOPHARM THERAPEUTICS INC
      摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

      专利号:AU-2022276509-A1
      优先权日:2021-05-20
      标题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

      专利号:US-9994558-B2
      优先权日:2013-09-20
      标题 :Multicyclic compounds and methods of using same
      发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
      权利人:KARYOPHARM THERAPEUTICS INC
      摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).

      专利号:US-7749985-B2
      优先权日:2006-09-15
      标 题 :Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
      发明人:GALLOP MARK A; XU FENG; PHAN THU; DILIP USHA; PENG GE
      权利人:XENOPORT INC
      摘要:Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, methods of making acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, methods of using acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, and pharmaceutical compositions comprising acyloxyalkyl carbamate prodrugs 3-aminopropylphosphinic acid and analogs thereof for treating diseases or disorders such as mild cognitive impairment, cognitive impairment associated with Alzheimer's disease Alzheimer's disease, depression, anxiety, and epilepsy are disclosed. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphinic acid and analogs thereof, which are suitable for oral administration and sustained release oral dosage forms are also disclosed.

      专利号:WO-2022246227-A1
      优先权日:2021-05-20
      标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Constantin M, Pognat JF. Pharmacokinetics of amixetrine in the dog. Relation of dose-to-plasma concentration. Arzneimittelforschung. 1978;28(4):646-51. French.

      合成参考文献


      摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知